TP53 and acute lymphoblastic leukemia: To determine whether the nucleolar stress response exhibits an anti-tumor effect, we investigated the function of TP53 wild-type BCP-ALL cells using actinomycin D. HDM201, an MDM2 inhibitor, was used as a negative control to demonstrate anti-tumor effects by increasing P53 regardless of the nucleolar stress response.